Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL358901

CC[n+]1ccn(C)c1.O=C([O-])C(F)(F)F

nearest known ligand 0.31

Full drug profile on Sugi Atlas →

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
FDPS P14324 3/20 0.31
MEN1 O00255 1/20 0.31
HSP90AA1 P07900 1/20 0.31
KMT2A Q03164 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Pivalate SCHEMBL2523721 0.88 ALDH1A1 (0.36) FDPSMEN1HSP90AA1KMT2ASMN1; SMN2
Trifluoroacetic Acid SCHEMBL27669831 0.88 MEN1 (0.32) MEN1HSP90AA1KMT2ASMN1; SMN2
Trifluoroacetic Acid SCHEMBL460211 0.88
Bicarbonate SCHEMBL2936301 0.88 MEN1 (0.35) FDPSMEN1HSP90AA1KMT2ASMN1; SMN2
SCHEMBL2399537 0.86 MEN1 (0.31) MEN1HSP90AA1KMT2ASMN1; SMN2
Bicarbonate SCHEMBL2229450 0.86 MEN1 (0.34) FDPSMEN1HSP90AA1KMT2ASMN1; SMN2
Bicarbonate SCHEMBL357950 0.86 MEN1 (0.34) FDPSMEN1HSP90AA1KMT2ASMN1; SMN2
Acetic Acid SCHEMBL302142 0.86 MEN1 (0.37) FDPSMEN1HSP90AA1KMT2ASMN1; SMN2
Trifluoroacetic Acid SCHEMBL302072 0.84 MEN1 (0.37) FDPSMEN1HSP90AA1KMT2ASMN1; SMN2
Acetic Acid SCHEMBL28948439 0.84 MEN1 (0.36) FDPSMEN1HSP90AA1KMT2ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 496 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025035278-A1 METHOD FOR REMOVING PVDF AND ALUMINUM FROM LITHIUM IRON PHOSPHATE POSITIVE ELECTRODE MATERIAL 广东邦普循环科技有限公司 2025-02-20 WO claimed
CN-119455902-A Modified silica gel and preparation method and adsorption application method thereof 天津派森新材料技术有限责任公司 2025-02-18 CN claimed
CN-119140058-A Modified silica gel and preparation method and adsorption application method thereof 天津派森新材料技术有限责任公司 2024-12-17 CN claimed
CN-117050023-A Method for preparing 5-fluorocytosine 浙江省化工研究院有限公司 2023-11-14 CN claimed
CN-115651186-A Method for preparing perfluoropolyether acid 浙江巨化技术中心有限公司 2023-01-31 CN claimed
CN-115295268-A Polymer-coated magnetic powder, preparation method thereof and magnet 深圳市优宝新材料科技有限公司 2022-11-04 CN claimed
CN-111662327-B Method for preparing phenyl phosphine dichloride 漯河市新旺化工有限公司 2022-09-23 CN claimed
US-20210395906-A1 ELECTROCHEMICAL DEBLOCKING SOLUTION FOR ELECTROCHEMICAL OLIGOMER SYNTHESIS ON AN ELECTRODE ARRAY CUSTOMARRAY INC (US) 2021-12-23 US claimed
CN-113741111-A Integrated electrochromic device and preparation method thereof 浙江工业大学 2021-12-03 CN claimed
CN-111690004-A Ionic liquid modified silica gel loaded aluminum chloride catalyst 山东卓俊实业有限公司 2020-09-22 CN claimed
US-20070176148-A1 Organic electroluminescence device SAMSUNG DISPLAY CO., LTD. (KR) 2007-08-02 US claimed
EP-1805206-A2 ELECTROCHEMICAL DEBLOCKING USING A HYDRAZINE DERIVATIVE Combimatrix Corporation (US) 2007-07-11 EP claimed
US-20070034513-A1 Electrochemical deblocking solution for electrochemical oligomer synthesis on an electrode array COMBIMATRIX CORPORATION 2007-02-15 US claimed
WO-2006105037-A2 ELECTROCHEMICAL DEBLOCKING SOLUTION FOR ELECTROCHEMICAL OLIGOMER SYNTHESIS ON AN ELECTRODE ARRAY COMBIMATRIX CORPORATION (US) 2006-10-05 WO claimed
US-20060147532-A1 Microparticles prepared using an ionic liquid AUSBORN MICHAEL 2006-07-06 US claimed
WO-2006031814-A2 ELECTROCHEMICAL DEBLOCKING USING A HYDRAZINE DERIVATIVE COMBIMATRIX CORPORATION (US) 2006-03-23 WO claimed
US-20060054511-A1 Electrochemical deblocking using a hydrazine derivative CUSTOMARRAY, INC. 2006-03-16 US claimed
EP-1569621-A1 MICROPARTICLES PREPARED USING AN IONIC LIQUID Novartis AG (CH) 2005-09-07 EP claimed
WO-2004052340-A1 MICROPARTICLES PREPARED USING AN IONIC LIQUID NOVARTIS AG (CH) 2004-06-24 WO claimed
US-20040005286-A1 Organic salt conditioner, organic salt-containing composition, and uses thereof L'OREAL (FR) 2004-01-08 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210395906-A1 ELECTROCHEMICAL DEBLOCKING SOLUTION FOR ELECTROCHEMICAL OLIGOMER SYNTHESIS ON AN ELECTRODE ARRAY DNMT1, DNASE1, DNPEP FDPS 3499/4885MEN1 1771/4885HSP90AA1 3933/4885
US-20040005286-A1 Organic salt conditioner, organic salt-containing composition, and uses thereof KRT18, HCN4, PRKDC FDPS 4495/4885MEN1 2676/4885HSP90AA1 3195/4885
US-20060147532-A1 Microparticles prepared using an ionic liquid FIBP, MIF, CHMP4B FDPS 2981/4885MEN1 1303/4885HSP90AA1 2183/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.